Evidence map›Paper›PMID 31409145›Full record

ArticleIntegrative cancer therapies

Ethanol Extracts of Dietary Herb,

Ching-Ying Kuo, Teng-Song Weng, K J Senthil Kumar, Yen-Hsueh Tseng, Ta-Wei Tung, Sheng-Yang Wang, Hui-Chun Wang

Open access · goldAbstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Essential Oils ofPlants (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ching-Ying Kuo1 Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Teng-Song Weng1 Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
K J Senthil Kumar3 Department of Forestry, National Chung-Hsing University, Taichung 40227, Taiwan.
Yen-Hsueh Tseng3 Department of Forestry, National Chung-Hsing University, Taichung 40227, Taiwan.
Ta-Wei Tung1 Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Sheng-Yang Wang3 Department of Forestry, National Chung-Hsing University, Taichung 40227, Taiwan.
Hui-Chun Wang1 Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0003-1414-1595
Kaohsiung Medical University · TWNational Chung Hsing University · TWNational Sun Yat-sen University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in mammography screening, chemotherapy, and adjuvant treatment modalities have improved the survival rate of women with breast cancer. Nevertheless, the breast tumor with metastatic progression is still life-threatening. Indeed, combination therapy with Ras-ERK and PI3K inhibitors is clinically effective in malignant breast cancer treatment. Constituents from genus

Indexed as

AlpiniaAntineoplastic AgentsBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationEpidermal Growth FactorErbB ReceptorsEthanolFemaleHumansMAP Kinase Signaling SystemMCF-7 CellsPhosphatidylinositol 3-KinasesPhosphorylationPlant ExtractsAntineoplastic AgentsEpidermal Growth FactorErbB ReceptorsEthanolPhosphatidylinositol 3-KinasesPlant ExtractsProto-Oncogene Proteins c-aktbreast cancerEGFRmetastasisPI3K/AKTRas-ERK

Identifiers

PMID31409145
PMCPMC6696839
OpenAlexW2968577728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.